Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBeximco Pharma Share News (BXP)

  • This share is currently suspended. It was suspended at a price of 42.50

Share Price Information for Beximco Pharma (BXP)

Share Price is delayed by 15 minutes
Get Live Data
42.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £189.60m
BXP Live PriceLast checked at - London Stock Exchange

Intraday Beximco Pharma Share Chart

Beximco Pharma News

Beximco wins licence to produce Covid treatment molnupiravir
20 Jan 2022

Beximco wins licence to produce Covid treatment molnupiravir

Beximco wins licence to produce Covid treatment molnupiravir

Beximco to offer Pfizer Covid pill as countries turn to new treatments
30 Dec 2021

Beximco to offer Pfizer Covid pill as countries turn to new treatments

Beximco to offer Pfizer Covid pill as countries turn to new treatments

LONDON MARKET MIDDAY: Stocks flat with Omicron still front of mind
30 Dec 2021

LONDON MARKET MIDDAY: Stocks flat with Omicron still front of mind

LONDON MARKET MIDDAY: Stocks flat with Omicron still front of mind

Beximco Pharmaceuticals offers first generic of Pfizer Covid-19 pill
30 Dec 2021

Beximco Pharmaceuticals offers first generic of Pfizer Covid-19 pill

Beximco Pharmaceuticals offers first generic of Pfizer Covid-19 pill

UK shareholder meetings calendar - next 7 days
16 Dec 2021

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

TRADING UPDATES: Beximco gets more Covid doses; AdEPT wins contract
8 Dec 2021

TRADING UPDATES: Beximco gets more Covid doses; AdEPT wins contract

TRADING UPDATES: Beximco gets more Covid doses; AdEPT wins contract

IN BRIEF: Beximco to distribute another 4.5 million jabs in Bangladesh
2 Dec 2021

IN BRIEF: Beximco to distribute another 4.5 million jabs in Bangladesh

IN BRIEF: Beximco to distribute another 4.5 million jabs in Bangladesh

IN BRIEF: Beximco confirms building ability to produce Covid vaccines
24 Nov 2021

IN BRIEF: Beximco confirms building ability to produce Covid vaccines

IN BRIEF: Beximco confirms building ability to produce Covid vaccines